Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study.
BACKGROUND
The role of admission blood glucose level on the prognosis of patients with intracerebral haemorrhage has not been elucidated.


OBJECTIVE
To examine this association on the basis of an epidemiologically representative patient material.


METHODS
249 500 people living in the catchment area of the Central Hospital of Central Finland. The diagnosis of ICH was established if verified by cranial computed tomography (CT) or autopsy.


RESULTS
Of the 416 patients who fulfilled the diagnostic criteria, 30 died before admission and 386 were admitted to the Central Hospital. All 329 patients (290 nondiabetics and 39 diabetics) with both admission blood glucose and cranial CT data were included in the study. The mean blood glucose level was 10.6 mmol/l for nondiabetics who died on the day of onset, 8.6 mmol/l for those dying during days 1 to 28, and 6.8 mmol/l for the 28 day survivors. The corresponding figures for diabetics were 13.9 mmol/l, 12.5 mmol/l, and 9.3 mmol/l. In both nondiabetics and diabetics, patients who died had significantly higher mean glucose than the 28 day survivors (p<0.0001 versus p = 0.029). However, blood glucose of the surviving diabetics was as high as that of the deceased nondiabetics (9.3 mmol/l versus 9.1 mmol/l). In nondiabetics, admission blood glucose was associated with parameters signifying severe stroke; disturbed consciousness, large haematoma volume and shift of cerebral midline structures, and high admission mean arterial pressure. In logistic regression analysis, high admission blood glucose in nondiabetics was a significant predictor of death during the first 28 days of onset (odds ratio 1.22, 95% CI 1.07 to 1.40).


CONCLUSIONS
High admission blood glucose predicts increased 28 day case fatality rate in both nondiabetic and diabetic patients with ICH. Because high admission blood glucose was associated with markers of severe stroke, we are inclined to support the stress theory; high admission blood glucose is the result of a serious ICH.
Fogelholm
R
R
Pappilantie 10 B 8, 02400 Kirkkonummi, Finland. r.fogel@kolumbus.fi
Murros
K
K
Rissanen
A
A
Avikainen
S
S
D000368:Aged; D001786:Blood Glucose / Q000032:analysis*; D002543:Cerebral Hemorrhage / Q000401:mortality* / Q000473:pathology*; D048909:Diabetes Complications / Q000401:mortality* / Q000473:pathology*; D016021:Epidemiologic Studies; D005260:Female; D005387:Finland / Q000453:epidemiology; D006801:Humans; D008297:Male; D011237:Predictive Value of Tests; D011379:Prognosis; D012189:Retrospective Studies; D012720:Severity of Illness Index; D016019:Survival Analysis
D001786:Blood Glucose
Stroke. 1999 Nov;30(11):2326-30
10548666
Eur Neurol. 1997;38(1):10-20
9252793
Stroke. 2001 Apr;32(4):891-7
11283388
Stroke. 2001 Oct;32(10):2426-32
11588337
Cerebrovasc Dis. 2001;12(3):159-70
11641579
J Neurol Sci. 2002 Apr 15;196(1-2):27-32
11959152
Eur J Neurol. 2002 May;9(3):297-301
11985639
Stroke. 2003 Jul;34(7):1717-22
12805488
Stroke. 2003 Aug;34(8):2060-5
12843354
Neurology. 2003 Nov 25;61(10):1351-6
14638954
J Neurol Sci. 1976 Oct;29(2-4):267-75
978211
Arch Neurol. 1985 Jul;42(7):661-3
4015462
Br Med J (Clin Res Ed). 1985 Oct 12;291(6501):1014-5
3931771
Diabet Med. 1987 May-Jun;4(3):237-40
2956026
Stroke. 1988 Feb;19(2):185-91
3344533
Age Ageing. 1988 May;17(3):164-70
3389245
Stroke. 1990 Sep;21(9):1376
2396278
Stroke. 1991 Jul;22(7):842-7
1853403
Ann Neurol. 1991 Jun;29(6):658-63
1842899
J Neurol Neurosurg Psychiatry. 1992 Jul;55(7):546-52
1640229
J Neurol Neurosurg Psychiatry. 1992 Aug;55(8):653-7
1527534
J Neurol Sci. 1992 Aug;111(1):59-64
1402998
J Neurol Sci. 1993 May;116(1):12-7
8509800
Stroke. 1993 Aug;24(8):1129-32
8342185
Q J Med. 1993 Jul;86(7):439-46
8210300
Stroke. 1994 Oct;25(10):1977-84
8091441
Acta Neurol Scand. 1995 Apr;91(4):306-9
7625160
Arch Neurol. 1995 Dec;52(12):1193-200
7492294
BMJ. 1997 May 3;314(7090):1303-6
9158464
Diabetes Care. 2000 Oct;23(10):1527-32
11023147